PM360

APRIL 4, 2025

The agencys data scientists develop data-driven HCP personas, providing clients with statistically significant insights into medical professionals responses across various therapeutic areas, specialties, and demographics. Rural-based HCPs expressed a strong need for treatments with manageable side effects and simplified dosing regimens.

Education 52

Education Sales Marketing Training 52

Pharma Marketing Network

NOVEMBER 15, 2024

Imagine having a tool that allows you to target specific audiences actively searching for healthcare solutions, like branded medications or treatment options. Think of PPC as a strategic way to reach people already searching for your product, whether it’s Eliquis , Keytruda , or a niche medical device. PPC does just that.

Marketing 52

Marketing Pharma Side effects Medical 52

pharmaphorum

JULY 1, 2022

billion buyout of Principia Biopharma has run into trouble, after the FDA placed it on partial clinical hold while a safety signal is investigated. Those changes haven’t been enough to prevent the FDA from taking action, although outside the US the studies will continue as planned with the tighter safety monitoring.

Side effects 98

Side effects Safety Biopharma Recruitment 98

Pharma Marketing Network

MARCH 5, 2025

With millions of healthcare professionals (HCPs) and patients turning to Google for medical information, paid search ads present a huge opportunity for pharma brands to boost engagement and conversions. Lead Generation: HCPs looking for drug samples, whitepapers, or medical education can be driven to tailored landing pages.

Management 52

Management Pharma Marketing Prescription 52

European Pharmaceutical Review

OCTOBER 18, 2022

The trial had a safety profile that was consistent with previous studies. Among the 170 axicabtagene ciloleucel-treated patients evaluable for safety, Grade ?3 Additionally, axicabtagene ciloleucel demonstrated a 2.5-fold

Side effects 111

Side effects Safety Patients Medical 111

European Pharmaceutical Review

DECEMBER 22, 2023

KarXT targets both the M1 and M4 muscarinic receptors, resulting in a differentiated safety and efficacy profile. It has demonstrated improvements in cognition and is not associated with common side effects of currently approved treatments like weight gain.

Food and Drug Administration 98

Food and Drug Administration Side effects Safety Food 98

Referral MD

FEBRUARY 28, 2025

While medical science advances, too many clinics still rely on cumbersome paperwork. For too long, the administrative side of healthcare has lagged behind its clinical advancements. These forms collect essential information, such as demographics, insurance details, medical history, and reason for visit.

Healthcare 52

Healthcare Healthcare Patients Electronics 52

Pharma Marketing Network

APRIL 10, 2025

What if the next patient who needs your medication is already searching onlineand youre not there? Dayparting lets marketers reach consumers during high-intent times, such as evenings or weekends when theyre researching symptoms or side effects. Gone are the days when print ads and in-person detailing alone could carry a brand.

Marketing 52

Marketing Pharma Networking Medical 52

European Pharmaceutical Review

NOVEMBER 2, 2023

The FDA said its approval of Wezlana is based on “a comprehensive review of scientific evidence demonstrating it is highly similar to Stelara and that there are no clinically meaningful differences between the two products in terms of safety, purity and potency.” Like Stelara, the most serious known side effect of Wezlana is infection.

Food and Drug Administration 98

Food and Drug Administration FDA Side effects Safety 98

Pharmaceutical Technology

NOVEMBER 14, 2022

A few months earlier, a Phase I study out of the the Medical University of South Carolina reported five out of six patients with lupus achieved responses as per the Systemic Lupus Erythematosus Responder Index (SRI), after receiving an infusion of mesenchymal stromal cells (MSCs). All five patients achieved remission after three months.

Side effects 144

Side effects Patients Manufacturing Safety 144

pharmaphorum

SEPTEMBER 16, 2022

The week 16 data of lebrikizumab […] points towards a drug with robust efficacy with hardly any safety trade-offs. Minor side effects to long-term maintenance balance. Any clinical study seeks to achieve maximum results efficacy with minimal occurrence of side effects. However, side effects do happen.

Management 100

Management Side effects Patients Safety 100

European Pharmaceutical Review

DECEMBER 18, 2023

Treatment-related side effects included nausea and headache but were generally mild. “As In terms of safety, they noted that being a part of the group calmed their fears and increased their sense of preparedness to engage in therapy. Participants described generally positive experiences.

Food and Drug Administration 116

Food and Drug Administration Patients Side effects Safety 116

Pharmaceutical Technology

NOVEMBER 23, 2022

The trial is designed to analyse the safety and efficacy of Hemgenix. A rise in liver enzymes, headache, increased blood enzyme level and flu-like symptoms among others were observed to be the most frequent side effects of the gene therapy. at six months and 24 months, respectively, following infusion.

Food and Drug Administration 105

Food and Drug Administration FDA Side effects Food 105

European Pharmaceutical Review

APRIL 20, 2023

“These results are exciting… this treatment led to fewer days with migraine for people who had already tried up to four other types of drugs to prevent migraine and either had no improvement or had side effects that outweighed any benefits,” commented study author Dr Patricia Pozo-Rosich, PhD at Vall d’Hebron University Hospital in Barcelona, Spain.

Side effects 98

Side effects Safety Medical Pharmaceutical 98

Pharma Marketing Network

MARCH 18, 2025

Keyword targeting helps brands connect with HCPs actively searching for medical advancements, treatment guidelines, or continuing education opportunities. Best For: Search-based intent, medical education campaigns, branded drug awareness. This includes: Disclosing risks and side effects in ad copy when mentioning drug benefits.

Pharma 52

Pharma Marketing Networking Healthcare 52

pharmaphorum

AUGUST 11, 2022

In 2016, the estimated annual cost of drug-related morbidity and mortality resulting from non-optimised medication therapy was $528.4 Pharmacogenomics, the understanding of how genes impact an individual’s response to medications, provides a potential outlet to better optimised therapies. billion in the United States alone.

Side effects 98

Side effects Medical Prescription Patients 98

Pharmatutor

JANUARY 23, 2023

Pharmacovigilance - Indian view of 2023 admin Tue, 01/24/2023 - 12:26 Pharmacovigilance is the process of monitoring and assessing the safety of medications after they have been approved and are on the market.

Side effects 52

Side effects Safety Medical Marketing 52

Pharma Marketing Network

MARCH 5, 2025

A single misstepsuch as targeting the wrong audience or omitting safety disclaimers can lead to regulatory violations and ad disapprovals. They use medical databases, clinical research platforms, and industry publications. Google and Facebook prohibit direct targeting based on medical conditions. The challenge?

Pharma 52

Pharma Networking Medical Healthcare 52

European Pharmaceutical Review

FEBRUARY 9, 2023

If progress continues in a Phase III clinical trial, this medication would be the first FDA-approved drug specifically for people with notalgia paresthetica. Side effects seen in the trial included headache, dizziness, constipation, and increased urine output occurred with difelikefalin. points for patients receiving placebo.

Food and Drug Administration 97

Food and Drug Administration FDA Side effects Medicine 97

pharmaphorum

JANUARY 3, 2023

. “New therapeutic options are desperately needed for treatment-resistant schizophrenia that occurs in approximately one third of patients,” commented Ravi Anand, Newron’s chief medical officer.

Side effects 105

Side effects Biopharma Patients Medical 105

Cesare Ferrari

OCTOBER 19, 2024

Having worked in medical sales for many years I think this unfavorable view is unjustified and this attitude to medical sales derives from misconceptions about selling. So, today I will discuss medical sales and explain its complexity and importance. Today the selling process is much more complex and multifaced.

Medical sales 52

Medical sales Sales Medical Medical sales reps 52

Pharma Marketing Network

MAY 3, 2023

Pharmaceutical marketing is a critical aspect of the industry, as it helps in spreading awareness about the benefits and potential side effects of different drugs. In conclusion, navigating the regulatory environment of pharmaceutical marketing requires a delicate balance between patient safety and industry innovation.

Safety 52

Safety Food and Drug Administration Pharmaceutical Marketing 52

pharmaphorum

JULY 19, 2022

Incyte’s Opzelura cream has become the first medical treatment approved to re-pigment the skin of people with vitiligo in the US, adding to its current use in atopic dermatitis. million people in the US.

FDA 98

FDA Side effects Sales Safety 98

Legacy MEDSearch

JULY 19, 2023

Francis Medical, Inc., “Currently, prostate cancer patients find themselves in the difficult position of balancing the oncological risks of the disease with the life-altering side effects that can often accompany traditional treatments. ” As the second most common cancer in U.S.

Medical 52

Medical Side effects Patients Recruitment 52

European Pharmaceutical Review

OCTOBER 12, 2022

A Phase III trial evaluating TauRx Therapeutics’ oral drug hydromethylthionine mesylate (HMTM), a tau aggression inhibitor, showed the medication continued to improve cognition over a pre-treatment baseline in patients with early Alzheimer’s for the first time. The safety data from the trial was consistent with earlier trial data.

Side effects 98

Side effects Safety Patients Sales 98

European Pharmaceutical Review

JANUARY 25, 2024

Within the EU, patient information leaflets (PILs) are not merely a regulatory requirement but a cornerstone of patient safety. They detail the medication’s intended use, proper administration, potential side effects and precautions.

Healthcare 98

Healthcare Healthcare Safety Electronics 98

PM360

NOVEMBER 29, 2022

Drug labels hold value for life sciences companies because they are rich, extensive documents that can be used across labeling, regulatory, safety, and medical affairs. Typically, a drug label refers to any information provided with prescription drugs, as requested by regulators such as the U.S.

Food and Drug Administration 98

Food and Drug Administration Competition Safety Pharmacology 98

Pharmaceutical Technology

FEBRUARY 17, 2023

In January, amidst calls to improve patient safety by optimizing licensed drug formulations, the FDA released a draft guidance that signalled a departure from the most commonly used method of identifying a new therapy’s ideal dosage. For this approach, a “3+3” model is used where a study enrolls three patients into a given dose cohort.

FDA 115

FDA Side effects Pharmacology Patients 115

European Pharmaceutical Review

DECEMBER 7, 2022

state the therapy could help reduce side effects and safety concerns. The study which similarly had patients receiving ivonescimab plus chemotherapy as their first line therapy for metastatic disease was considered to have demonstrated a tolerable safety profile and a low discontinuation rate for adverse events (AEs).

Pharma 98

Pharma Side effects Safety Patients 98

Contrarian Sales Techniques

FEBRUARY 25, 2023

A point of view from a Medical Sales Rep I strongly believe that the most effective insurance policy is not to get sick. But it is crucial to remember that not all illnesses are preventable, and some may require medical treatment, such as accidents or injuries. This is before a drug can be approved for public use.

Side effects 52

Side effects Medical sales reps Insurance Medical sales 52

European Pharmaceutical Review

MARCH 24, 2023

Following the recent announcement of topline results from 89bio’s Phase IIb trial, ENLIVEN, evaluating FGF21 analogue pegozafermin for nonalcoholic steatohepatitis (NASH), a serious liver condition, EPR spoke with Dr Hank Mansbach, the company’s Chief Medical Officer. About the authors Dr Hank Mansbach is Chief Medical Officer of 89bio.

Medical 108

Medical Side effects Safety Pharmaceutical 108

PM360

AUGUST 9, 2022

How can we help ensure patients continue to take their medications as prescribed? Doctors, caregivers, life sciences companies, and even companies in other industries have attempted to answer this question for as long as medications have been available. But it is not a simple answer. from 2021 and reach $4.2 billion in 2025.

Prescription 105

Prescription Medical Patients Side effects 105

PM360

AUGUST 9, 2022

PM360 asked life sciences industry experts with knowledge about improving adherence to medication to share the latest trends and approaches being used and to tell us how better data and monitoring can help solve this issue. How can the industry better measure adherence to medication and monitor it at both a large and small scale?

Medical 105

Medical Patients Electronics Healthcare 105

European Pharmaceutical Review

JUNE 12, 2024

The main objective was to evaluate the efficacy and safety of MBK-01 compared to fidaxomicin, providing significant insights into the potential of MBK-01 as a treatment for primary or recurrent CDI and contributing to the advancement of microbiome-based therapies. The study included 92 adult patients with confirmed CDI.

Safety 111

Safety Patients Side effects Healthcare 111

European Pharmaceutical Review

OCTOBER 17, 2024

Additionally, EURneffy could alleviate the risk of accidental needle-related side effects (such as injection into the blood vessel and hand) 3 and it has the attributes of being smaller in size, has better temperature sensitivity, and is less complex to use compared to needle-based injectors. Motohiro E, Kento T, Kyohei T , et al.

Food and Drug Administration 121

Food and Drug Administration Medicine Consulting Food 121

Pharma Marketing Network

JULY 19, 2023

This blog post could provide information about the drug’s potential benefits, its side effects, and how it compares to other drugs on the market. For example, a pharmaceutical company could create a white paper about a particular medical condition.

Marketing 98

Marketing Pharmaceutical Sales Education 98

Pharmaceutical Technology

JANUARY 27, 2023

As for Briumvi’s side effects, around 45% of patients experienced infections of the upper respiratory tract, which was 4% higher in comparison to Aubagio. However, the short infusion times might attract patients newly diagnosed with MS and help medical centers with high throughput to treat more patients per slot.

Marketing 52

Marketing Side effects Safety Patients 52